Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute kidney injury (CA-AKI), which is associated with increased mortality. According to current guidelines, the standard treatment for preventing CA-AKI in patients with moderate to severe CKD is long-duration peri-procedural intravenous hydration with saline solution.

Hidratación intravenosa rápida simplificada para prevención de nefropatía por contraste en pacientes con enfermedad renal crónica

This standard hydration is carried out from 12 hours before to 24 hours after the procedure. However, recent studies have suggested that short-duration hydration, using the RenalGuard system or guided by left ventricular end-diastolic pressure, could be a safe option.

The aim of this randomized controlled multicenter study was to assess whether simplified hydration (SH) was non-inferior to standard hydration for the prevention of CA-AKI in high-risk CKD patients undergoing elective coronary angiography or percutaneous coronary intervention (PCI).

The primary endpoint was the incidence of CA-AKI, defined as an increase of at least 25% or an absolute increase of 0.5 mg/dL in serum creatinine levels during the first 48-72 hours after the procedure. The secondary endpoint included different definitions of CA-AKI; major adverse cardiovascular events (MACE) defined as all-cause mortality, non-fatal myocardial infarction, and rehospitalization; changes in glomerular filtration rate; persistent contrast-induced renal injury; and hospitalization costs. Additionally, the occurrence of acute heart failure after the procedure during hospitalization was established as the safety endpoint.

Out of 1,002 patients, 501 were randomly assigned to the SH group and the other 501 to the control group. The average age was 69 years, and most subjects were men. The mean baseline estimated glomerular filtration rate (eGFR) was 45.8 ± 11.7 mL/min/1.73 m2, and the average contrast volume was 115 mL, with no significant differences between the two groups. The total duration of hydration in the control group was four times longer than in the SH group (25 vs. 6 hours; p <0.001).

Read also: TAVR Durability at 5 Years in Intermediate Risk Patients.

Regarding the results, the overall incidence of CA-AKI was 7.3%, with a rate of 6.2% in the SH group and 8.4% in the control group (risk ratio [RR]: 0.8; 95% confidence interval [CI]: 0.5-1.2; p = 0.216). There were no significant differences between the two groups in the secondary endpoint.

Conclusion

The simplified hydration protocol was shown to be non-inferior to the standard hydration protocol in preventing CA-AKI in CKD patients undergoing coronary angiography. Furthermore, SH did not increase the risk of heart failure. Further studies are needed to evaluate the effect of CA-AKI prevention in patients with severe coronary lesions or emergency PCI.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Simplified Rapid Hydration Prevents Contrast-Associated Acute Kidney Injury Among CKD Patients Undergoing Coronary Angiography.

Reference: Yong Liu, MD, PHD et al J Am Coll Cardiol Intv 2023;16:1503–1513.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...